Alliancebernstein L.P. Mersana Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

  • $261 Billion
  • Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 186,060 shares of MRSN stock, worth $70,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186,060
Previous 186,060 -0.0%
Holding current value
$70,702
Previous $266,000 76.32%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.0 - $4.45 $34,500 - $76,762
17,250 Added 10.22%
186,060 $373,000
Q1 2024

May 14, 2024
BUY
$2.16 - $5.94 $109,360 - $300,742
50,630 Added 42.84%
168,810 $756,000
Q4 2023

Feb 14, 2024
SELL
$1.11 - $2.34 $13,941 - $29,390
-12,560 Reduced 9.61%
118,180 $274,000
Q3 2023

Nov 14, 2023
SELL
$1.06 - $3.91 $91,138 - $336,181
-85,980 Reduced 39.67%
130,740 $166,000
Q2 2023

Aug 15, 2023
BUY
$3.08 - $9.55 $360,421 - $1.12 Million
117,020 Added 117.37%
216,720 $713,000
Q3 2022

Nov 15, 2022
BUY
$4.63 - $8.0 $45,374 - $78,400
9,800 Added 10.9%
99,700 $674,000
Q2 2022

Aug 15, 2022
BUY
$2.84 - $5.0 $35,784 - $63,000
12,600 Added 16.3%
89,900 $415,000
Q1 2022

May 13, 2022
BUY
$3.74 - $6.63 $748 - $1,326
200 Added 0.26%
77,300 $308,000
Q4 2021

Feb 14, 2022
BUY
$5.48 - $9.86 $27,948 - $50,286
5,100 Added 7.08%
77,100 $480,000
Q1 2021

May 06, 2021
SELL
$15.31 - $26.52 $96,453 - $167,076
-6,300 Reduced 8.05%
72,000 $1.17 Million
Q3 2020

Nov 12, 2020
BUY
$16.2 - $25.7 $16,200 - $25,700
1,000 Added 1.29%
78,300 $1.46 Million
Q2 2020

Aug 13, 2020
BUY
$5.24 - $23.4 $200,692 - $896,220
38,300 Added 98.21%
77,300 $1.81 Million
Q1 2020

May 14, 2020
BUY
$4.41 - $9.28 $114,219 - $240,351
25,900 Added 197.71%
39,000 $227,000
Q2 2019

Aug 14, 2019
BUY
$3.84 - $6.4 $50,304 - $83,840
13,100 New
13,100 $53,000
Q3 2018

Nov 08, 2018
SELL
$10.0 - $19.02 $579,000 - $1.1 Million
-57,900 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$14.2 - $22.68 $822,180 - $1.31 Million
57,900 New
57,900 $1.03 Million

Others Institutions Holding MRSN

# of Institutions
116
Shares Held
101M
Call Options Held
16.3K
Put Options Held
13K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $36.9M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email